Invesaro

Stocks LSCC Financial statements

Financial statements

LATTICE SEMICONDUCTOR CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data LATTICE SEMICONDUCTOR CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue427386399404408515660737509523
Cost of revenue180169179166163194208222169166
Gross profit247217219238245322452515340357
Research and development11810382.478.689.2111136160159188
Selling, general and administrative98.690.791.182.595.3106122137117154
Operating expenses264223179193221265302306346
Operating income-26.7-47.6-3.125952.410118721234.511.2
Interest expense20.318.820.611.73.72.744.152.970.270.26
Other non-operating income2.84-3.29-0.25-2.25-0.21-0.45-1.110.55-2.18-0.75
Pre-tax income-44.2-69.7-2445.148.597.618221536.213.4
Income tax9.920.852.351.571.061.73.23-44.2-24.910.3
Net income-54.1-70.6-26.343.547.495.917925961.13.08
EBITDA35.110.236.192.164.211320123053.831.1
EPS, basic-0.45-0.58-0.210.330.350.701.301.880.440.02
EPS, diluted-0.45-0.58-0.210.320.340.671.271.850.440.02
Shares, basic (weighted)120123127132135137137138138137
Shares, diluted (weighted)120123127137141142141140138138

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents107107119118182132146128136134
Short-term investments4.987.450
Receivables99.655.160.964.964.679.99410481.1102
Inventory79.279.967.15564.667.611098.810389.2
Other current assets1916.627.824.522.322.329.136.444.138.5
Total current assets315263284262334301379368365364
Property, plant and equipment49.540.434.939.239.738.147.649.55377
Lease right-of-use assets023.622.223.817.614.513.939.5
Goodwill270268268268268315315315315315
Intangible assets11951.321.36.986.3229.825.1214.594.14
Long-term investments02.170
Other non-current assets13.713.115.311.810.518.112.914.825.320.6
Total assets767636624612680726799841844883
Accounts payable37.835.431.944.427.534.64234.536.856.5
Accrued liabilities9.8710.49.3720.621.426.448.53645.630.6
Deferred revenue0.730.0703.074.7717.75.311.24.01
Short-term debt33.81.518.2921.512.817.20
Total current liabilities15883.669.499.879.710612797.499.6118
Long-term debt3013002511251581411290
Lease liabilities21.418.919.213.610.79.4336.1
Other non-current liabilities383544.53839.148.741.840.723.915.3
Total liabilities496418365284296315312149133169
Total debt3353012511251721591290
Paid-in capital680696736762771702599546504504
Retained earnings-407-478-477-433-386-290-111148209212
Other comprehensive income-4.16-1.45-2.33-2.6-1.75-1.45-2.41-2.91-3.84-3.14
Shareholders' equity270245258328384412487692711714
Total equity270245258328384412487692711714
Total liabilities and equity767636624612680726799841844883
Shares outstanding122124130134136137137137138137

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income-54.1-70.6-26.343.547.495.917925961.13.08
Depreciation and amortization61.857.939.333.111.81213.817.319.319.9
Stock-based compensation16.212.513.618.940.446.555.570.253116
Deferred income tax0.090.01-0.09-0.32-0.08-0.32-1.42-58.6-12.15.19
Change in receivables-11.444.6-3.98-4.030.34-12-14.2-10.423.3-21.2
Change in inventory-3.27-0.913.212.1-9.62-3-42.811.5-4.5814.2
Change in payables8.34-23.6-3.4712.5-16.87.057.44-7.552.3419.7
Cash from operations41.738.551.512491.7168239270141175
Capital expenditures-16.7-12.9-8.38-15.6-12.1-9.84-23.3-20.1-21-42.5
Acquisitions0000-68.100
Purchases of investments-1-7.42-9.60
Sales and maturities of investments14.912.759.6600
Cash from investing-17.4-8.26-21.1-15.5-20.9-89.8-34.9-33.3-37.7-62.3
Debt issued50014900
Debt repaid-5.15-35.4-43.8-321-26.3-13.1-179-13000
Stock issued7.616.0929.317.210.18.837.168.376.187.59
Share buybacks0000-15-70.1-110-80-67-100
Cash from financing-1.11-32.6-16.8-110-8.1-129-188-254-94.5-116
Exchange rate effect-1.32.62-1.270.34
Net change in cash21.90.2612.2-0.9764.3-50.814.2-17.47.97-2.41
Free cash flow2525.743.110979.6158215249120133
Interest paid18.220.618.6113.72.313.973.2400
Income taxes paid9.362.393.053.391.873.34.6215.88.597.77

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 4, 2026; growth uses fiscal years. Valuation uses the share price of $128.05 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin69.0%Gross profit / revenue.
Operating margin7.4%Operating income / revenue.
Pre-tax margin6.9%Pre-tax income / revenue.
Net margin5.6%Net income / revenue.
FCF margin30.6%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin37.4%Cash from operations / revenue.
Effective tax rate18.9%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)4.6%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)3.7%Net income / average total assets.
Return on invested capital (ROIC)6.3%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue33.5%Research and development expense / revenue.
SG&A / revenue27.0%Selling, general and administrative expense / revenue.
Stock-based pay / revenue18.7%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue6.8%Capital expenditures / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y2.7%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-7.5%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y5.1%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y4.9%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-7.6%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y7.8%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y-67.4%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y-60.9%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y-26.5%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y-42.1%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y-46.3%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y-13.5%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-95.0%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y-74.2%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y-42.1%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y-95.5%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y-74.9%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y-43.3%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y24.3%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y-9.8%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y13.8%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y10.6%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y-14.9%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y10.8%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y0.4%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y13.6%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y13.2%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y4.6%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y3.4%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y5.4%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-0.1%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-0.6%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-0.4%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio3.02xCurrent assets / current liabilities.
Quick ratio2.02x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio1.20x(Cash + short-term investments) / current liabilities.
Liabilities / assets19.3%Total liabilities / total assets.
Working capital$293.3MCurrent assets - current liabilities.
Goodwill and intangibles / assets34.4%(Goodwill + intangible assets) / total assets.
Tangible book value$452.1MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.67xRevenue / average total assets.
Fixed asset turnover8.08xRevenue / average property, plant and equipment.
Inventory turnover2.01xCost of revenue / average inventory.
Days inventory182 days365 x average inventory / cost of revenue.
Receivables turnover5.42xRevenue / average receivables.
Days sales outstanding67 days365 x average receivables / revenue.
Days payables146 days365 x average accounts payable / cost of revenue.
Cash conversion cycle103 daysDays inventory + days sales outstanding - days payables.
FCF conversion547.9%Free cash flow / net income, when net income is positive.
Capex / operating cash flow18.2%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$0.26Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$4.64Revenue / diluted weighted shares.
FCF per share$1.42Free cash flow / diluted weighted shares.
Operating cash flow per share$1.73Cash from operations / diluted weighted shares.
Book value per share$5.74Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$3.30Tangible book value / shares outstanding.
Cash per share$1.26(Cash + short-term investments) / shares outstanding.
Buybacks / FCF22.2%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$18.19BShare price x shares outstanding.
Enterprise value$18.01BMarket cap + total debt - cash - short-term investments.
P/E501xMarket cap / net income. Only when net income is positive.
P/S27.9xMarket cap / revenue.
P/B23.1xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book40.2xMarket cap / tangible book value, when positive.
P/FCF91.4xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF74.8xMarket cap / cash from operations, when positive.
EV/Sales27.7xEnterprise value / revenue.
EV/EBIT375xEnterprise value / operating income, when both are positive.
EV/FCF90.5xEnterprise value / free cash flow, when both are positive.
FCF yield1.1%Free cash flow / market cap.
Earnings yield0.2%Net income / market cap (the inverse of P/E).
Shareholder yield0.2%(Dividends paid + share buybacks) / market cap.
What was LATTICE SEMICONDUCTOR CORP's revenue in fiscal 2025?

LATTICE SEMICONDUCTOR CORP reported revenue of $523.3M for fiscal 2025, 2.7% higher than the year before.

Was LATTICE SEMICONDUCTOR CORP profitable in fiscal 2025?

Yes. Net income was $3.1M, a net margin of 0.6%.

How much free cash flow did LATTICE SEMICONDUCTOR CORP generate in fiscal 2025?

Cash from operations of $175.1M minus capital expenditures of $42.5M left free cash flow of $132.6M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to LATTICE SEMICONDUCTOR CORP